RECENT PRODUCT NEWS

AQUILANT ENDOSCOPY, the exclusive provider of Fujifilm endoscopy equipment in the UK, supported the BSG Annual Meeting at Liverpool's ACC venue between 20-23 June 2016, by launching a range of new solutions and sponsoring a number of key initiatives, including:

In order to further the mission to simplify diabetes management, ABBOTT has announced a mobile app that will enable people with diabetes to access glucose data directly from their FreeStyle Libre sensor, on their smartphones.

Researchers at the Italian National Research Council and the University of Pisa, Italy, are set to transform research into skin disorders, performing in vivo histological examination with the aid of FUJIFILM VisualSonics' Vevo MD ultra high frequency ultrasound system.

CEPHEID has announced that its Xpert HIV-1 Qual (Qualitative) test has been awarded World Health Organization (WHO) prequalification, making it one of the first molecular point of care tests designed for HIV to be given this designation.

Radiometer has unveiled its CE-marked TCM5 transcutaneous monitor, addressing the critical care needs of neonatal, pediatric and adult patients, as well as sleep clinic and home care environments.

Following a successful first intake onto new healthcare engineering foundation degrees, Eastwood Park is taking applications for September for its new BSc (Hons) in Management of Healthcare Engineering Technologies and Facilities.

Synbiosis is launching ChromaZona – an IVD certified instrument for microbial identification and antimicrobial susceptibility testing (AST).

Molecular diagnostics specialist Cepheid is bringing its Xperience mobile virtual laboratory to the UK, showcasing the advantages of the company’s innovative GeneXpert technology.

BD (Becton, Dickinson and Company) has launched a new safety blood collection set – the BD Vacutainer UltraTouch Push Button Blood Collection Set – in the UK, after achieving European CE marking.

From a single endoscope to a fully integrated operating theatre, KARL STORZoffers high quality, innovative products and solutions for a vast range of GI procedures.

OLYMPUS will be showcasing the very latest innovations available for endoscopy at BSG, and will also be sponsoring the evening symposia “‘Back to the future’ – meeting the rising demand for endoscopy from an endoscopist’s point of view”.

WASSENBURG is a global specialist in flexible endoscope reprocessing and has been dedicated to the design and manufacture of Endoscope Washer Disinfectors and Dryer/Storage cabinets for more than 30 years.

MEDISAFE’s new and improved Hemoclip offers a 360 degree rotation designed for haemostasis.

PARTNERS FOR ENDOSCOPY will showcase an irrigation system which ensures 100% sterile water, endoscopes giving 360-degree vision and innovative new scope storage systems.

Participating at this year’s BSG meeting for the very first time, ENTERAL UK is a leading supplier of enteral feeding devices.

Helicobacter TestINFAIis a breath test for direct, non-invasive detection of the bacterium Helicobacter pylori.

CANTEL MEDICAL is a leading global company providing innovative solutions at every step of an endoscope’s journey, from procedure room products and bedside pre-cleaning, through to disinfection and validated storage, protecting staff, assets and patients from infection and risk.

Workwear provider, GRAHAME GARDNER, has unveiled an innovative new range of garments, bringing uniform design together with the latest in sportswear technology. The Leicester-based firm has launched its ‘Advance’ collection in response to increasing demand from businesses for more customisable and contemporary uniforms that provide increased comfort and resilience.

At the recent Tissue Viability Society conference in Cardiff, TALLEY launched its new product literature and an interactive, tablet based, interface pressure educational Applet. The new brochure focuses on the top of the range Quattro Therapy Mattress Systems and it highlights the clinical benefits these products can offer healthcare providers who are actively seeking to reduce their pressure ulcer incidence.

Faecal calprotectin (fCAL) has become an increasingly important biomarker for in vitro diagnostic detection of gut inflammation. It enables clinicians to make initial diagnostic predictions without the need for invasive and costly endoscopies. With the advent of NICE diagnostics guidance [DG11], the demand for faecal calprotectin testing has risen significantly.